Literature DB >> 26119038

Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.

Joanne Neale1, John Strang2.   

Abstract

AIM: To analyse drug users' views and experiences of naloxone during emergency resuscitation after illicit opiate overdose to identify (i) any evidence of harm caused by excessive naloxone dosing ('over-antagonism'); and (ii) implications for the medical administration of naloxone within contemporary emergency settings.
DESIGN: Re-analysis of a large qualitative data set comprising 70 face-to-face interviews conducted within a few hours of heroin/opioid overdose occurring, observations from hospital settings and a further 130 interviews with illicit opiate users. Data were generated between 1997 and 1999.
SETTING: Emergency departments, drug services and pharmacies in two Scottish cities. PARTICIPANTS: Two hundred illicit opiate users: 131 males and 69 females.
FINDINGS: Participants had limited knowledge of naloxone and its pharmacology, yet described it routinely in negative terms and were critical of its medical administration. In particular, they complained that naloxone induced acute withdrawal symptoms, causing patients to refuse treatment, become aggressive, discharge themselves from hospital and take additional street drugs to counter the naloxone effects. Participants believed that hospital staff should administer naloxone selectively and cautiously, and prescribe counter-naloxone medication if dosing precipitated withdrawals. In contrast, observational data indicated that participants did not always know that they had received naloxone and hospital doctors did not necessarily administer it incautiously.
CONCLUSIONS: Opiate users in urban Scotland repeatedly report harm caused by naloxone over-antagonism, although this is not evident in observational data. The concept of contemporary legend (a form of folklore that can be based on fact and provides a means of communicating and negotiating anxiety) helps to explain why naloxone has such a feared reputation among opiate users.
© 2015 Society for the Study of Addiction.

Entities:  

Keywords:  Contemporary legend; naloxone; opiates; overdose; qualitative study

Mesh:

Substances:

Year:  2015        PMID: 26119038     DOI: 10.1111/add.13027

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  19 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.

Authors:  Joanne Neale; Caral Brown; Aimee N C Campbell; Jermaine D Jones; Verena E Metz; John Strang; Sandra D Comer
Journal:  Addiction       Date:  2018-12-28       Impact factor: 6.526

3.  Changes in cardiac vagal tone as measured by heart rate variability during naloxone-induced opioid withdrawal.

Authors:  Charles J Levin; Jonathan M Wai; Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2019-09-03       Impact factor: 4.492

4.  Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study.

Authors:  Stephen Parkin; Joanne Neale; Caral Brown; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2020-04-15

5.  Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Authors:  Nadia Fairbairn; Phillip O Coffin; Alexander Y Walley
Journal:  Int J Drug Policy       Date:  2017-07-04

6.  UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDS.

Authors:  Joanne Neale; Adrian Farrugia; Aimee N Campbell; Paul Dietze; Robyn Dwyer; Renae Fomiatti; Jermaine D Jones; Sandra D Comer; Suzanne Fraser; John Strang
Journal:  Drugs (Abingdon Engl)       Date:  2021-02-22

7.  Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.

Authors:  Joanne Neale; Nicola J Kalk; Stephen Parkin; Caral Brown; Laura Brandt; Aimee N C Campbell; Felipe Castillo; Jermaine D Jones; John Strang; Sandra D Comer
Journal:  J Subst Abuse Treat       Date:  2020-08-05

8.  Emotional reactions of trained overdose responders who use opioids following intervention in an overdose event.

Authors:  Laura Brandt; Aimee N C Campbell; Jermaine D Jones; Suky Martinez; Joanne Neale; Stephen Parkin; Caral Brown; John Strang; Sandra D Comer
Journal:  Subst Abus       Date:  2021-09-14       Impact factor: 3.716

9.  Cannabinoid CB2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression.

Authors:  Carmen A Zavala; Ana C Thomaz; Vishakh Iyer; Ken Mackie; Andrea G Hohmann
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-21

10.  A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.

Authors:  Stephen Parkin; Joanne Neale; Caral Brown; Jermaine D Jones; Laura Brandt; Felipe Castillo; Aimee N C Campbell; John Strang; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.